Ruthenium(II)‐Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria‐Targeted Apoptotic Cell Death
Chemistry – A European Journal · 2023
DOI: 10.1002/chem.202202694 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2023. Verfasst von Gurunath Sahu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, National Institute of Technology, Rourkela, 769008, Odisha, India. Hauptthemen laut MEDLINE: Ruthenium, Antineoplastic Agents, Coordination Complexes. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Council for Scientific and Industrial Research, India, Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
The reaction of the Ru(PPh 3 ) 3 Cl 2 with HL 1−3 −OH (−OH stands for the oxime hydroxyl group; HL 1 −OH=diacetylmonoxime‐S‐benzyldithiocarbazonate; HL 2 −OH=diacetylmonoxime‐S‐(4‐methyl)benzyldithiocarbazonate; and HL 3 −OH=diacetylmonoxime‐S‐(4‐chloro)benzyl‐dithiocarbazonate) gives three new ruthenium complexes [Ru II (L 1−3 −H)(PPh 3 ) 2 Cl] ( 1 – 3 ) (−H stands for imine hydrogen) coordinated with dithiocarbazate imine as the final products. All ruthenium(II) complexes ( 1 – 3 ) have been characterized by elemental (CHNS) analyses, IR, UV‐vis, NMR ( 1 H, 13 C, and 31 P) spectroscopy, HR‐ESI‐MS spectrometry and also, the structure of 1 – 2 was further confirmed by single crystal X‐ray crystallography. The solution/aqueous stability, hydrophobicity, DNA interactions, and cell viability studies of 1 – 3 against HeLa, HT‐29, and NIH‐3T3 cell lines were performed. Cell viability results suggested 3 being the most cytotoxic of the series with IC 50 6.9±0.2 μM against HeLa cells. Further, an apoptotic mechanism of cell death was confirmed by cell cycle analysis and Annexin V‐FITC/PI double staining techniques. In this regard, the live cell confocal microscopy results revealed that compounds primarily target the mitochondria against HeLa, and HT‐29 cell lines. Moreover, these ruthenium complexes elevate the ROS level by inducing mitochondria targeting apoptotic cell death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, National Institute of Technology, Rourkela, 769008, Odisha, India.
- Institut für Anorganische und Analytische Chemie, Friedrich-Schiller-Universität Jena, Humboldtstr. 8, 07743, Jena, Germany.
Förderung
- Council for Scientific and Industrial Research, India
- Council of Scientific and Industrial Research, India
Zitieren
APA
Sahu, G., Patra, S. A., Lima, S., Das, S., Görls, H., Plass, W., & Dinda, R. (2023). Ruthenium(II)‐Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria‐Targeted Apoptotic Cell Death. Chemistry – A European Journal. https://doi.org/10.1002/chem.202202694
Vancouver
Sahu G, Patra SA, Lima S, Das S, Görls H, Plass W, et al. Ruthenium(II)‐Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria‐Targeted Apoptotic Cell Death. Chemistry – A European Journal. 2023. doi:10.1002/chem.202202694
BibTeX
@article{Sahu2023,
author = {Sahu, Gurunath and Patra, Sushree Aradhana and Lima, Sudhir and Das, Sanchita and Görls, Helmar and Plass, Winfried and Dinda, Rupam},
title = {Ruthenium(II)‐Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria‐Targeted Apoptotic Cell Death},
journal = {Chemistry – A European Journal},
year = {2023},
doi = {10.1002/chem.202202694}
}
EUVIMED